The development of many different chromogens for light microscopy gives us the opportunity to explore different usage of multiplex immunohistochemistry (IHC) for clinical diagnostic purposes as well ...
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue, a life science company developing reagent-driven strategies for high-performance biological imaging in situ, today announced expanded capabilities of its ...
Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC ...
Collaboration to bolster end-to-end services from assay development to confident informed clinical decision making MUNICH and KASSEL, Germany, June 20, 2019 /CNW/ -- Definiens, a leading international ...
The prognostic value of Sprouty2 protein in nonsmall cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.
PLEASANTON, Calif.--(BUSINESS WIRE)--Diagnostic Biosystems (DBS), a specialty Immunohistochemistry company, announces its debut as an automated IHC company, introducing the Mosaic 360™ System with a ...
Analysis methods enhance our understanding of spatial biology, providing deeper insights into cellular interactions and tissue architecture. In this webinar, we will explore the intricacies of ...
Multiplex immunohistochemistry (IHC) technologies are powerful tools to visualize multiple markers in the same tissue sample. These techniques, which include tyramide signal amplification and cyclic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback